Turkish Validation Study of Endometriosis Health Profile -30 (EHP-30) Test
NCT ID: NCT04862364
Last Updated: 2021-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
228 participants
OBSERVATIONAL
2021-04-26
2021-08-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation ( Endometriosis Health Profile) EHP-30 (Turkish Version) for Patients With Endometriosis
NCT03744377
Evaluation of Serum Ages Levels in Patients With Endometriosis
NCT04886024
Endometrial Biopsy as Diagnostic Method for Endometriosis and Endometrioma
NCT01022372
Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis
NCT03302468
EHP-5 in Preoperative Assessment in Women With Endometriosis
NCT04491305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endo Patients with Endometriosis Health Profile -30 (EHP-30) Test
The appointment of the patients consists of patients who were surgically diagnosed with Endometriosis in our clinic.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18- 45
* not being pregnant
Exclusion Criteria
* above 45 and under 18 years old
* use psichiatrig drugs
* being diagnosed with a psychiatric illness
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Engin Oral
UNKNOWN
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pınar Yalcin bahat
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ehp-30turkishvalidation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.